These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33243427)

  • 1. Synthesis and immunogenicity of Brucella monovalent neoglycoconjugate.
    Hao T; Wang H; Liu J; Zhang Q; Liu Y; Zhao L; Zhu T; Yu P; Guo N; Meng X
    Carbohydr Res; 2021 Jan; 499():108196. PubMed ID: 33243427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular recognition of Brucella A and M antigens dissected by synthetic oligosaccharide glycoconjugates leads to a disaccharide diagnostic for brucellosis.
    Ganesh NV; Sadowska JM; Sarkar S; Howells L; McGiven J; Bundle DR
    J Am Chem Soc; 2014 Nov; 136(46):16260-9. PubMed ID: 25263136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic glycoconjugates characterize the fine specificity of Brucella A and M monoclonal antibodies.
    Mandal SS; Ganesh NV; Sadowska JM; Bundle DR
    Org Biomol Chem; 2017 May; 15(18):3874-3883. PubMed ID: 28317992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved serodiagnosis of bovine brucellosis by novel synthetic oligosaccharide antigens representing the capping m epitope elements of Brucella O-polysaccharide.
    McGiven J; Howells L; Duncombe L; Stack J; Ganesh NV; Guiard J; Bundle DR
    J Clin Microbiol; 2015 Apr; 53(4):1204-10. PubMed ID: 25653412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brucellosis: Improved Diagnostics and Vaccine Insights from Synthetic Glycans.
    Bundle DR; McGiven J
    Acc Chem Res; 2017 Dec; 50(12):2958-2967. PubMed ID: 29219305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New synthesis of oligosaccharides modelling the M epitope of the
    Tsvetkov YE; Volkov TM; Eremin SA; Sklyarov OD; Kulakov YK; Krylov VB; Nifantiev NE
    Front Chem; 2024; 12():1424157. PubMed ID: 38974993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition of Brucella A and M epitopes by monoclonal typing reagents and synthetic oligosaccharides.
    Bundle DR; Cherwonogrodzky JW; Gidney MA; Meikle PJ; Perry MB; Peters T
    Infect Immun; 1989 Sep; 57(9):2829-36. PubMed ID: 2474505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinvestigation of the structure of Brucella O-antigens.
    Kubler-Kielb J; Vinogradov E
    Carbohydr Res; 2013 Aug; 378():144-7. PubMed ID: 23664729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on immunogenicity and antigenicity of a novel brucella multiepitope recombined protein.
    Yin D; Bai Q; Li L; Xu K; Zhang J
    Biochem Biophys Res Commun; 2021 Feb; 540():37-41. PubMed ID: 33429198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-Polysaccharide epitopic heterogeneity at the surface of Brucella spp. studied by enzyme-linked immunosorbent assay and flow cytometry.
    Cloeckaert A; Weynants V; Godfroid J; Verger JM; Grayon M; Zygmunt MS
    Clin Diagn Lab Immunol; 1998 Nov; 5(6):862-70. PubMed ID: 9801349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the Omp16 Epitopes for the Development of an Epitope-based Vaccine Against Brucellosis.
    Rezaei M; Rabbani-Khorasgani M; Zarkesh-Esfahani SH; Emamzadeh R; Abtahi H
    Infect Disord Drug Targets; 2019; 19(1):36-45. PubMed ID: 29984663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine structure of A and M antigens from Brucella biovars.
    Meikle PJ; Perry MB; Cherwonogrodzky JW; Bundle DR
    Infect Immun; 1989 Sep; 57(9):2820-8. PubMed ID: 2474504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
    Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines.
    Jiménez de Bagüés MP; Elzer PH; Blasco JM; Marín CM; Gamazo C; Winter AJ
    Infect Immun; 1994 Feb; 62(2):632-8. PubMed ID: 8300219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with poly I:C against Brucella melitensis and Brucella abortus infection.
    Sadeghi Z; Fasihi-Ramandi M; Bouzari S
    Int Immunopharmacol; 2019 Oct; 75():105829. PubMed ID: 31437796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antibody and protective responses in mice by Brucella O-polysaccharide-BSA conjugate.
    Jacques I; Olivier-Bernardin V; Dubray G
    Vaccine; 1991 Dec; 9(12):896-900. PubMed ID: 1811374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Immune Effects Between
    Zhu L; Wang Q; Wang Y; Xu Y; Peng D; Huang H; Hu L; Wei K; Zhu R
    Front Vet Sci; 2020; 7():576. PubMed ID: 33195494
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis of antigenic determinants of the Brucella A antigen, utilizing methyl 4-azido-4,6-dideoxy-alpha-D-mannopyranoside efficiently derived from D-mannose.
    Bundle DR; Gerken M; Peters T
    Carbohydr Res; 1988 Mar; 174():239-51. PubMed ID: 2454158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of a neoglycoconjugate containing a Chlamydophila psittaci-specific branched Kdo trisaccharide epitope.
    Kosma P; Hofinger A; Müller-Loennies S; Brade H
    Carbohydr Res; 2010 Mar; 345(5):704-8. PubMed ID: 20116048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural elucidation of the Brucella melitensis M antigen by high-resolution NMR at 500 MHz.
    Bundle DR; Cherwonogrodzky JW; Perry MB
    Biochemistry; 1987 Dec; 26(26):8717-26. PubMed ID: 3442684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.